New Jersey Local News, Breaking News, Sports & Business.

Dr. Ozmocked for backhanded endorsement from Chris Christie: 'New Jersey Robust' – New York Every day Information

[ad_1]

Even the endorsements are hurting Dr. Oz.

The TV physician took one other hit on social media after Chris Christie praised him as “a longtime New Jerseyan,” the worst sort of backing within the essential Pennsylvania U.S. Senate race.

“Chris Christie. Dr. Oz. Deeply unpopular however NEW JERSEY STRONG,” tweeted Lt. Gov. John Fetterman, Ozs Democratic opponent.

Fetterman wasted no time leaping on backhanded endorsement from the previous New Jersey governor, who left workplace with an approval score barely out of the one digits.

Christie mentioned Ozduring a political look in upstate New York, the place he blasted Republicans for backing former President Donald Trump.

“I defend Dr. Ozbecause he’s a longtime New Jerseyan,” Christie said. “The issue is he’s operating in Pennsylvania.

Ozhas been awkwardly dodging carpetbagger allegations since he moved his official residence from northern New Jersey to the Philadelphia suburbs to run for the seat left open by the retiring Sen. Pat Toomey (R-Pa.)

He took warmth from Fetterman followers Snooki from ‘Jersey Shore’ and Jersey rock icon Steve Van Zandt for his deep roots within the Backyard State.

The celeb doctor made issues worse for himself when he mentioned the woes of buying ingredients for “crudité” at a Pennsylvania grocery store, suggesting he could also be out of contact with the issues of blue-collar voters. For good measure, Ozalso butchered the identify of the grocery retailer.

The gaffes have helped Fetterman open up a strong lead within the race that would decide management of the evenly matched U.S. Senate.

Fetterman has battled questions on his well being after he suffered a gentle stroke on the eve of the Democratic main, which he received convincingly.

The 2 males are set to conflict in a high-stakes debate subsequent month forward of the November election.

[ad_2]

Comments are closed.